Current Vascular Pharmacology
Title: Editorial [PCI and Stable Coronary Heart Disease - COURAGE to Change Our Minds?]
Volume: 5 Issue: 3
Author(s): Anna I. Kakafika, Dimitri P. Mikhailidis, Anthony S. Wierzbicki, Asterios Karagiannis and Vasilios G. Athyros
Affiliation:
Keywords: Percutaneous coronary intervention, stents, medical treatment, treatment cost
Export Options
About this article
Cite this article as:
Anna I. Kakafika , Dimitri P. Mikhailidis , Anthony S. Wierzbicki , Asterios Karagiannis and Vasilios G. Athyros , Editorial [PCI and Stable Coronary Heart Disease - COURAGE to Change Our Minds?], Current Vascular Pharmacology 2007; 5 (3) . https://dx.doi.org/10.2174/157016107781024145
DOI https://dx.doi.org/10.2174/157016107781024145 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Functional PLGA NPs for Oral Drug Delivery: Recent Strategies and Developments
Mini-Reviews in Medicinal Chemistry Intravenous Thrombolysis with rt-PA in Acute Stroke Patients Aged ≥80 Years
Letters in Drug Design & Discovery A Review of Premature Frailty in HIV-Infected Persons; Another Manifestation of HIV-Related Accelerated Aging
Current Aging Science Diet, Cardiometabolic Factors and Type-2 Diabetes Mellitus: The Role of Genetics
Current Diabetes Reviews Docking Studies for Multi-Target Drugs
Current Drug Targets Editorial: Vascular Calcification, Cardiovascular Risk and microRNAs
Current Vascular Pharmacology Prevention and Treatment of Venous Thromboembolism and Pulmonary Embolism: The Role of Novel Oral Anticoagulants
Current Clinical Pharmacology Adrenergic and V1-ergic Agonists/Antagonists Affecting Recovery from Brain Trauma in the Lund Project Act on Astrocytes
Current Signal Transduction Therapy A Comparative Assessment of Metabolic Syndrome and its Association with Vitamin D and Other Risk Factors in Type 2 Diabetes Mellitus Patients
Current Diabetes Reviews Traditional and Novel Risk Factors of Diabetic Retinopathy and Research Challenges
Current Medicinal Chemistry Genetics of Ion Channels in Sudden Unexplained Death Syndrome: Moving Beyond Idiopathic Reactions To Personalized Risk Assessment
Current Pharmacogenomics and Personalized Medicine The Application of Cell-Penetrating-Peptides in Antibacterial Agents
Current Medicinal Chemistry Pulmonary Vasodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery
Current Vascular Pharmacology ACE2 and Diabetic Complications
Current Pharmaceutical Design Clinical Utility of Acarbose, an α-Glucosidase Inhibitor in Cardiometabolic Disorders
Current Drug Metabolism Ximelagatran - A Promising New Drug in Thromboembolic Disorders
Current Pharmaceutical Design The Road to Device Miniaturization in Echocardiography
Recent Patents on Medical Imaging T Cell-based Therapies for Atherosclerosis
Current Pharmaceutical Design The Role of An Experimental Model of Atherosclerosis: apoE-knockout Mice in Developing New Drugs against Atherogenesis
Current Pharmaceutical Biotechnology Pharmacotherapy of Sickle Cell Disease in Children
Current Pharmaceutical Design